ADUVANZ, created in 2013 (Ireland), from 440 sister brands and 4958 competing brands. The ADUVANZ brand is owned by Takeda Pharmaceutical, a company listed in Francfort. Its International Securities Identification Number (ISIN) is JP3463000004. ADUVANZ is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Takeda Pharmaceutical
(ADUVANZ)
over 5 years*
EUR 18.63